Form 4: Exelixis Director Stelios Papadopoulos Exercises Options and Sells Shares

Director Stelios Papadopoulos exercised stock options and sold shares of Exelixis, Inc. on May 20, 2024.

Summary

• On May 20, 2024, Stelios Papadopoulos, a director of Exelixis, Inc., exercised options to purchase 11,686 shares of common stock at a price of $19.57 per share.
• Simultaneously, Papadopoulos sold 11,437 shares of common stock at a weighted average price of $21.
• Following these transactions, Papadopoulos beneficially owns 1,260,578 shares of Exelixis common stock, which includes 20,718 shares issuable upon vesting of restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the buying and selling activities of company directors. It's common for executives to exercise stock options and sell a portion of the acquired shares for personal financial management.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The transactions are typical for executives holding stock options as part of their compensation packages.
• The reported prices are within the normal trading range for Exelixis stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.
• The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates